Vimarsana
Biggest News Aggregation in the World

Williamb Bonello News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Williamb Bonello. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Williamb Bonello Today - Breaking & Trending Today

NeoGenomics, Inc.: RaDaR Assay Demonstrates Clinical Potential for Detecting Disease Recurrence Across All Types of Early Breast Cancer, Including Triple Negative Disease - Vimarsana News

NeoGenomics, Inc.: RaDaR Assay Demonstrates Clinical Potential for Detecting Disease Recurrence Across All Types of Early Breast Cancer, Including Triple Negative Disease

Data presented at this year's San Antonio Breast Cancer Symposium builds on strong base of evidence supporting promise of RaDaR in helping prevent recurrence and improving outcomesFT. MYERS, FL / ACCESSWIRE

NeoGenomics, Inc.: NeoGenomics and ImmunoGen Launch New Program Giving Ovarian Cancer Patients Access to Novel FR Biomarker Testing to Support the Launch of ELAHERE - Vimarsana News

NeoGenomics, Inc.: NeoGenomics and ImmunoGen Launch New Program Giving Ovarian Cancer Patients Access to Novel FR Biomarker Testing to Support the Launch of ELAHERE

Program leverages NeoGenomics' expertise to provide ovarian cancer patients critical insights to ensure they are getting the right treatmentFT. MYERS, FL / ACCESSWIRE / November 18, 2022 / NeoGenomics

NeoGenomics, Inc.: NeoGenomics Reports Third Quarter 2022 Results - Vimarsana News

NeoGenomics, Inc.: NeoGenomics Reports Third Quarter 2022 Results

Third Quarter Revenue Increased 6% to $129 MillionFORT MYERS, FL / ACCESSWIRE / November 8, 2022 / NeoGenomics, Inc. (NASDAQ:NEO) (the "Company"), a leading provider of cancer-focused genetics testing

NeoGenomics Reports Third Quarter 2022 Results - Vimarsana News

NeoGenomics Reports Third Quarter 2022 Results

08.11.2022 - Third Quarter Revenue Increased 6% to $129 MillionFORT MYERS, FL / ACCESSWIRE / November 8, 2022 / NeoGenomics, Inc. (NASDAQ:NEO) (the 'Company'), a leading provider of cancer-focused genetics testing services and global oncology contract research ...

NeoGenomics, Inc.: NeoGenomics Appoints David Perez, Industry Veteran and Former Terumo BCT CEO, to Its Board of Directors - Vimarsana News

NeoGenomics, Inc.: NeoGenomics Appoints David Perez, Industry Veteran and Former Terumo BCT CEO, to Its Board of Directors

FT. MYERS, FL / ACCESSWIRE / November 7, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, has appointed David B. Perez - a veteran leader